Category Archives: Insulin Sensitivity

Successful Clinical Trial of Type 2 Drug That Works on Intestinal Organisms

BROOMFIELD, Colo.–MicroBiome TherapeuticsTM has announced positive results from its clinical trial of a microbiome modulator, NM504, in development for type 2 diabetes and pre-diabetes.

NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with diabetes …